Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine.
Macklin GR, O'Reilly KM, Grassly NC, Edmunds WJ, Mach O, Santhana Gopala Krishnan R, Voorman A, Vertefeuille JF, Abdelwahab J, Gumede N, Goel A, Sosler S, Sever J, Bandyopadhyay AS, Pallansch MA, Nandy R, Mkanda P, Diop OM, Sutter RW. Macklin GR, et al. Science. 2020 Apr 24;368(6489):401-405. doi: 10.1126/science.aba1238. Epub 2020 Mar 19. Science. 2020. PMID: 32193361 Free PMC article.
Final frontiers of the polio eradication endgame.
Bandyopadhyay AS, Macklin GR. Bandyopadhyay AS, et al. Among authors: macklin gr. Curr Opin Infect Dis. 2020 Oct;33(5):404-410. doi: 10.1097/QCO.0000000000000667. Curr Opin Infect Dis. 2020. PMID: 32773500 Review.
Fractional-dose IPV in polio eradication.
Macklin GR, Mach O. Macklin GR, et al. Lancet Infect Dis. 2021 Aug;21(8):1061-1062. doi: 10.1016/S1473-3099(20)30774-X. Epub 2021 Apr 30. Lancet Infect Dis. 2021. PMID: 33939959 No abstract available.
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Macklin GR, Peak C, Eisenhawer M, Kurji F, Mach O, Konz J, Gast C, Bachtiar NS, Bandyopadhyay AS, Zipursky S; nOPV2 Working Group. Macklin GR, et al. Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A122-A127. doi: 10.1016/j.vaccine.2022.02.050. Epub 2022 Mar 17. Vaccine. 2023. PMID: 35307230 Free PMC article.
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
Martin J, Burns CC, Jorba J, Shulman LM, Macadam A, Klapsa D, Majumdar M, Bullows J, Frolov A, Mate R, Bujaki E, Castro CJ, Bullard K, Konz J, Hawes K, Gauld J, Blake IM, Mercer LD, Kurji F, Voorman A, Diop OM, Oberste MS, Modlin J, Macklin G, Eisenhawer M, Bandyopadhyay AS, Zipursky S. Martin J, et al. MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):786-790. doi: 10.15585/mmwr.mm7124a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35709073 Free article.
16 results